vasculitis remission
Showing 1 - 25 of 3,066
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Trial in Boston (Rituximab)
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
-
Boston, MassachusettsMassachusetts General Hospital
Jul 28, 2021
Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia
Not yet recruiting
- Granulomatosis With Polyangiitis
- +2 more
-
Boston, Massachusetts
- +2 more
Dec 29, 2022
ANCA Associated Vasculitis Trial in Netherlands (Rituximab, endoxan, Methylprednisolone)
Recruiting
- ANCA Associated Vasculitis
- Rituximab
- +3 more
-
Leiden, Zuid-Holland, Netherlands
- +3 more
May 16, 2022
Granulomatosis With Polyangiitis, Wegener Granulomatosis, Vasculitis Trial in Tampa (5 mg prednisone, 0 mg prednisone)
Active, not recruiting
- Granulomatosis With Polyangiitis
- +2 more
- 5 mg prednisone
- 0 mg prednisone
-
Tampa, FloridaUniversity of South Florida TAPIR Study Team
May 2, 2022
Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)
Recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Feb 9, 2022
Granulomatosis With Polyangiitis Trial in Canada, United States (5 mg Prednisone, 0 mg Prednisone)
Recruiting
- Granulomatosis With Polyangiitis
- 5 mg Prednisone
- 0 mg Prednisone
-
Kansas City, Kansas
- +8 more
Jan 25, 2022
Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial in Paris (Rituximab, Placebo-rituximab, Cyclophosphamide)
Completed
- Eosinophilic Granulomatosis With Polyangiitis (EGPA)
- Rituximab
- +3 more
-
Paris, FranceHôpital Cochin
Apr 13, 2021
ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)
Recruiting
- ANCA Associated Vasculitis
- Telitacicept
- Placebo of Telitacicept
-
Beijing, ChinaPeking Union Medical College Hospital
Jul 19, 2023
Antineutrophil Cytoplasmic Antibody-associated Vasculitis Trial (Avacopan, Placebo, Standard of Care)
Not yet recruiting
- Antineutrophil Cytoplasmic Antibody-associated Vasculitis
- Avacopan
- +2 more
- (no location specified)
Oct 6, 2023
IgA Vasculitis Trial in France (Rituximab Injection, )
Recruiting
- IgA Vasculitis
- Rituximab Injection
- placebo
-
Brest, France
- +13 more
Apr 8, 2022
ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)
Recruiting
- ANCA Associated Vasculitis
- +2 more
-
Edinburgh, United KingdomCentre for Cardiovascular Science, Queen's Medical Research Inst
Jan 26, 2023
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared
Recruiting
- ANCA-associated Vasculitis
- +2 more
-
Calgary, Alberta, Canada
- +8 more
Jan 27, 2023
Subclinical Cytomegalovirus Reactivation in Acute
Recruiting
- ANCA Associated Vasculitis
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham
Jan 15, 2023
Wegeners Granulomatosis (Granulomatosis With Polyangiitis), Microscopic Polyangiitis, Churg Strauss Syndrome (Eosinophilic
Recruiting
- Wegeners Granulomatosis (Granulomatosis With Polyangiitis)
- +6 more
-
San Francisco, California
- +37 more
Nov 4, 2022
Necrotizing Vasculitis, Neuropathy Trial in France (Necrotizing Vasculitis)
Recruiting
- Necrotizing Vasculitis
- Neuropathy
- Necrotizing Vasculitis
-
Angers, France
- +39 more
Jun 29, 2022
Urinary T Lymphocytes Predict Renal Flares in Inactive
Completed
- Glomerulonephritis Acute
- Analysis of urine samples with flow cytometry
-
Berlin, Germany
- +1 more
Mar 8, 2022
ANCA-associated Vasculitis Trial in China (BDB-001 injection, Cyclophosphamide, Glucocorticoids)
Recruiting
- ANCA-associated Vasculitis
- BDB-001 injection
- +2 more
-
Hefei, Anhui, China
- +19 more
Apr 29, 2022
Severity in Juvenile and Adult-onset Dermatomyositis
Not yet recruiting
- Dermatomyositis
- evaluation of clinical severity
- (no location specified)
Aug 16, 2023
POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia Trial in Hangzhou (CD19/BCMA CAR T-cells)
Recruiting
- POEMS Syndrome
- +3 more
- CD19/BCMA CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Feb 21, 2022
Granulomatosis With Polyangiitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Paris (Rituximab,
Not yet recruiting
- Granulomatosis With Polyangiitis
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- Rituximab
- +2 more
-
Paris, FranceHôpital de la Croix Saint Simon
Oct 10, 2022
ANCA Associated Vasculitis, Microscopic Polyangiitis, Churg-Strauss Syndrome Trial in United Kingdom (Hydroxychloroquine,
Recruiting
- ANCA Associated Vasculitis
- +3 more
- Hydroxychloroquine
- Placebo
-
Cardiff, United Kingdom
- +8 more
Mar 17, 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis Trial in Worldwide
Completed
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- +2 more
- Rituximab
- Azathioprine
-
Los Angeles, California
- +37 more
Feb 18, 2022
Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)
Recruiting
- Giant Cell Arteritis
- Methotrexate
- Sodium chloride
-
Bonn, GermanyMedical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022
ANCA Associated Vasculitis, Granulomatosis With Polyangiitis Trial in United Kingdom (Belimumab, Rituximab, Prednisolone)
Active, not recruiting
- ANCA Associated Vasculitis
- Granulomatosis With Polyangiitis
- Belimumab
- +2 more
-
Cambridge, United Kingdom
- +5 more
Feb 21, 2022